Is cyclosporine withdrawal a therapeutic option in renal transplant recipients with chronic allograft dysfunction
D Ducloux
The Italian journal of urology and nephrology 55 ( 1) 81 -89
2003
Facteurs de risque cardio-vasculaire traditionnels en transplantation rénale : TRANSPLANTATION RENALE: COMPLICATIONS ET FACTEURS DE RISQUE CARDIO-VASCULAIRE
D Ducloux
Le courrier de la transplantation 11 ( 1) 15 -19
2011
CYA WITHDRAWAL IN STABLE RENAL TRANSPLANT RECIPIENTS AFTER AZA - MMF SWITCH: A PILOT STUDY.
Ch Legendre , E Morelon , D Ducloux , L Bererhi
Transplantation 67 ( 7) S116
1999
A NEW INDUCTION STRATEGY WITH A PRETRANSPLANT BOLUS OF POLYCLONAL ANTIBODIES: POSITIVE IMPACT ON LONG-TERM PATIENT AND GRAFT SURVIVAL OF ATG FRESENIUS VERSUS THYMOGLOBULINE.
Y Saint-Hillier , E Racadot , V Fournier , C Bresson-Vautrin
Transplantation 67 ( 7)
1999
Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients
AB Abdelfatah , G Motte , D Ducloux , JM Chalopin
Journal of Human Hypertension 15 ( 11) 775 -779
20
2001
CLINICAL RELEVANCE OF PRE-TRANSPLANT ADIPONECTIN LEVELS FOR PREDICTION OF NEW-ONSET DIABETES AFTER TRANSPLANTATION: 1074
A Kazory , C Courivaud , S Mercier , S Kury-Paulin
Transplantation 86 368
2008
Anti-class II antibodies in kidney transplant patients
J.M Rebibou , M.C Bittencourt , D Ducloux , J Chabod
Congress of the Portuguese Transplantation Society 32 ( 8) 2748 -2749
3
2000
A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
E Thervet , E Morelon , D Ducloux , L Bererhi
Congress of the Portuguese Transplantation Society 32 ( 8) 2778 -2778
4
2000
Colchicine myopathy in renal transplant recipients on cyclosporin.
D Ducloux , V Schuller , C Bresson-Vautrin , JM Chalopin
Nephrology Dialysis Transplantation 12 ( 11) 2389 -2392
35
1997
Anti-beta 2-glycoprotein I and anti-prothrombin antibodies in haemodialysis patients.
D Ducloux , A Florea , JM Rebibou , M Jamali
Nephrology Dialysis Transplantation 12 ( 11) 2466 -2467
5
1997
Renal papillary necrosis in a marathon runner
D Ducloux , A Lemouel , JM Chalopin
Nephrology Dialysis Transplantation 14 ( 1) 247 -248
5
1999
Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies.
D Ducloux , A Florea , V Fournier , JM Rebibou
Nephrology Dialysis Transplantation 14 ( 5) 1335 -1336
9
1999
LYMPHOCYTES SUBSETS IN RENAL TRANSPLANT RECIPIENTS WITH DE NOVO GENITOURINARY MALIGNANCIES: 2128
G Guichard , J-M Rebibou , D Simula-Faivre , D Ducloux
Transplantation 86 697
2008
IMPACT OF CYCLOSPORINE REDUCTION WITH MMF IN CHRONIC ALLOGRAFT DYSFUNCTION: 4-YEAR RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED STUDY. The “REFERENCE” STUDY.
M Kessler , L Frimat , E Cassuto-Viguier , B Charpentier
Transplantation 82 ( 1) 353 -354
2
2006
COVID-19 et transplantation d’organes, les leçons du recensement national de la Société francophone de transplantation
Sophie Caillard , S Caillard , B Moulin , S Fafi-Kremer
Bulletin de l'Academie nationale de medecine 206 ( 4) 511 -517
2022
Impact de l’induction par anticorps polyclonaux anti-lymphocytes T sur la récidive de la néphropathie à IgA: étude PIRAT
N Maillard , N Kamar , J Dantal , O Thaunat
Néphrologie & Thérapeutique 17 ( 5) 291 -292
2021
LONG-TERM FOLLOW-UP OF KIDNEY TRANSPLANT RECIPIENTS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: LESSONS FROM THE FRENCH REGISTRY
X Bassand , O Thaunat , F Provot , D Anglicheau
TRANSPLANT INTERNATIONAL 33 27 -27
2020
Effect of vildagliptin added to insulin on glycaemic control in haemodialysis patients with type 2 diabetes: a randomised multicentre prospective study
A Smagala , M Munch , L Meyer , A Klein
DIABETOLOGIA 61 S510 -S511
2018
KIDNEY TRANSPLANTATION AFTER BONE MARROW ALLOGRAFT
MJ Ziliotis , L Frimat , M Buchler , P Malvezzi
TRANSPLANT INTERNATIONAL 30 ( SUP S 1) 16 -16
2017
Relecteurs 2015 pour Néphrologie & thérapeutique
R Azar , C Basile , P Bataille , C Béchade
Néphrologie & Thérapeutique 11 589 -589
2015